Skip to content

Clinical and Health Economic Impact of Robot-assisted Surgery vs Conventional Laparoscopy : the Case of Gastric Bypass

Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760512
Enrollment
118
Registered
2013-01-04
Start date
2012-11-30
Completion date
2015-06-30
Last updated
2015-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Gastric bypass, Robot-assisted surgery, Conventional laparoscopy, Pain assessment, Health economics outcomes

Brief summary

The purpose of this study is to gather clinical and economic evidence on the use of robotics for bariatric surgery (gastric bypass). This monocentric, randomized, single blind, controlled study will evaluate post-operative pain, quality of life and appetite, post-operative complication incidence. It will also provide information on direct and indirect costs of surgery.

Detailed description

Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery (Gastric Bypass): a prospective, single-blind, randomized, non-inferiority, and controlled study The main evaluation criterion is 24h post-operative pain assessed using visual analog scale (VAS). Secondary criteria included for clinical assessment: post 24h pain, excess weight loss, quality of life, appetite, complications, conversion rate; and for health-economics assessment : duration of surgical steps, length of stay, return to normal activity and their conversion to cost, consumables, estimation of indirect costs and benefits (e.g., robotics perception, publication). In this study, main inclusion criteria include major obesity (IMC ≥ 35) with co-morbidities or morbid obesity (IMC ≥ 40), scheduled gastric bypass surgery Main contraindications are previous bariatric surgery and previous major abdominal surgeries To test robotic-assisted surgery non-inferiority on VAS pain score 24h post-surgery, a total of 128 patients (64 per arm) is to be included (alpha 2,5%; power 90%; drop-out rate: 5%). The study will include 12 months of follow-up post-surgery for each patient. The total study duration is 2 years and 3 months.

Interventions

PROCEDUREGastric bypass

Gastric bypass

Sponsors

IHU Strasbourg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patient presenting with major obesity (BMI ≥ 35) with co-morbidities or morbid obesity (BMI ≥ 40)according to French HAS (Haute Autorité de Santé) and CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salariés)criteria for whom gastric bypass is scheduled * Male or female between 18 and 65 years old * Patient registered with the French Social Security * Patient having provided a written informed consent prior to enrolment * Patient accepting to attend follow-up visits as required by study protocol

Exclusion criteria

* Patient with a BMI ≥ 60 * Patient with a contraindication for laparoscopic gastric bypass with or without robotic assistance * Patient having had prior bariatric surgery * Patient having had prior major abdominal surgery * Patient in exclusion period of another clinical study * Patient pregnant or breastfeeding * Patient without sufficient knowledge of french language or unable to receive or understand study related information and answer to questionnaires * Patient with no or limited legal capacity

Design outcomes

Primary

MeasureTime frameDescription
24h postoperative pain24hPain assessment 24h post surgery (visual analog scale)

Secondary

MeasureTime frameDescription
Evaluation of quality of life (BAROS and GIQLI)At 1, 3, 6 and 12 monthsEvaluation of quality of life using BAROS and GIQLI questionaires
Evaluation of appetite levelAt 8 days, 1, 3, 6 and 12 monthsEvaluation of appetite level using VAS
Percentage of excess weight lossAt 8 days, 1, 3, 6 and 12 monthsMeasure of excess weight loss - % from baseline
Conversion rate to conventional laparoscopyDuring the procedure (Day 0)Conversion rate to conventional laparoscopy (only applicable to robot-assisted surgery arm)
Evaluation of post-operative pain24h, 8 days, 1, 3, 6 and 12 monthsEvaluation of post-operative pain (beyond 24h post-operative) using VAS
Nature of post-operative complicationsFollowing the procedure (Day 0) up to 12 monthsNature of post-operative complications
Evaluation of operative timesDuring the procedure (Day 0)Evaluation of key steps of gastric bypass surgery, OR occupation time
Evaluation of direct costsDuring the procedure (day 0) and up to 12 monthsDirect costs include material used, OR occupation time, length of stay, return to normal activity
Evaluation of indirect costsUp to 12 monthsCombination of number of patients having surgery, perception of robot-assisted surgery by both personnel and patients, publications, and communications
Nature of per-operative complicationsDuring the procedure (Day 0)Nature of per-operative complications

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026